Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Nicotine
Drug ID BADD_D01564
Description Nicotine is highly toxic alkaloid. It is the prototypical agonist at nicotinic cholinergic receptors where it dramatically stimulates neurons and ultimately blocks synaptic transmission. Nicotine is also important medically because of its presence in tobacco smoke.
Indications and Usage For the relief of nicotine withdrawal symptoms and as an aid to smoking cessation.
Marketing Status approved
ATC Code N07BA01
DrugBank ID DB00184
KEGG ID D03365
MeSH ID D009538
PubChem ID 89594
TTD Drug ID D0T8GD
NDC Product Code 17205-601; 58316-010; 11673-195; 11673-879; 37808-900; 37808-948; 43598-447; 59450-003; 59779-443; 70000-0115; 0536-1107; 70677-0030; 52922-001; 58316-009; 75877-0002; 11822-3627; 11822-4975; 21130-820; 37808-533; 37808-658; 43598-448; 49035-195; 55910-313; 66715-9802; 66715-9805; 66715-9806; 70000-0114; 28663-009; 58316-006; 11673-727; 11673-881; 37808-682; 0135-0196; 37808-711; 37808-739; 49035-196; 53329-192; 59450-002; 60429-443; 60429-445; 62011-0351; 63868-734; 70677-0032; 60429-444; 0363-0455; 0363-0457; 66715-9804; 68016-288; 28663-010; 58316-011; 11822-4973; 37808-753; 43598-446; 0009-5401; 50090-1148; 53329-193; 68016-289; 0536-1108; 58316-008; 29485-5271; 50090-2860; 63981-124; 66715-9803; 68196-194; 0536-1106; 61252-3005; 50090-1697; 59450-001; 63981-190; 70677-0031; 0135-0194; 0135-0195; 49035-782; 49348-788; 50090-2837; 59779-445; 62011-0350; 63868-735; 66715-9801; 68016-290; 69842-828; 50392-101; 55742-003; 11673-971; 11822-4974; 37808-707; 37808-849; 50090-6383; 55741-449; 59779-448; 0363-0451; 62011-0349; 81870-001; 11673-269; 11673-424; 21130-269; 43598-445; 53329-191; 69842-605; 70000-0113; 58316-007; 11673-194; 11673-196; 29485-5270; 37808-383; 37808-911; 49035-194; 0009-5400
UNII 6M3C89ZY6R
Synonyms Nicotine | Nicotine Bitartrate | Nicotine Tartrate
Chemical Information
Molecular Formula C10H14N2
CAS Registry Number 54-11-5; 22083-74-5
SMILES CN1CCCC1C2=CN=CC=C2
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Dysstasia15.03.05.011; 08.01.03.089; 17.02.02.012--Not Available
Intervertebral disc protrusion15.10.01.0040.000940%Not Available
Musculoskeletal chest pain22.09.01.001; 15.03.04.0120.001379%
Necrotising colitis07.08.01.0130.000940%Not Available
Nasal discomfort22.12.03.0120.003197%Not Available
Cardiac flutter02.03.02.012--Not Available
Musculoskeletal discomfort15.03.04.001--Not Available
Application site swelling12.07.01.027; 08.02.01.0270.002445%Not Available
Affect lability19.04.01.001--Not Available
Skin burning sensation23.03.03.021; 17.02.06.0090.002445%Not Available
Foetal death18.01.02.003; 08.04.01.0110.000627%
Urine odour abnormal20.02.01.0200.002131%Not Available
Hypoaesthesia oral07.05.05.003; 17.02.06.0210.002445%Not Available
Paraesthesia oral17.02.06.008; 07.05.05.0350.001379%Not Available
Nicotine dependence19.07.06.0170.085000%Not Available
Lung neoplasm malignant22.08.01.001; 16.19.02.0010.001881%Not Available
Adnexa uteri mass21.07.04.0050.000940%Not Available
Application site discolouration08.02.01.030; 23.03.03.023; 12.07.01.0300.001379%Not Available
Application site scar08.02.01.033; 23.03.11.010; 12.07.01.0330.000940%Not Available
Intestinal haemorrhage24.07.02.031; 07.12.03.0050.000627%Not Available
Tobacco withdrawal symptoms19.07.06.022; 08.06.02.017--Not Available
Hot flush24.03.01.005; 21.02.02.001; 08.01.03.027--
General symptom08.01.03.0210.000627%Not Available
Adverse event08.06.01.0100.004012%Not Available
Brain neoplasm17.20.01.003; 16.30.01.0030.000627%Not Available
Cardiac disorder02.11.01.003--Not Available
Mediastinal disorder22.09.03.001--Not Available
Mental disorder19.07.01.0020.001254%Not Available
Motor dysfunction17.01.02.031; 15.05.06.006--Not Available
Temperature regulation disorder05.03.04.013; 08.05.01.0040.000627%Not Available
The 12th Page    First    Pre   12 13 14    Next   Last    Total 14 Pages
ADReCS-Target
Drug Name ADR Term Target
Tip:  Drug Name  ADR Term  Protein  Variation  Gene